FOXO4-DRI

What is FOXO4-DRI?

FOXO4-DRI represents molecular precision in anti-aging research. Senescent cells—aged cells that cease dividing but resist apoptosis—accumulate with age and secrete inflammatory factors (the senescence-associated secretory phenotype, SASP) that damage surrounding tissues. Dutch researchers discovered that in senescent cells, FOXO4 protein binds and sequesters p53, preventing p53-mediated apoptosis. FOXO4-DRI, a peptide mimicking the p53-binding domain of FOXO4, competitively disrupts this interaction—freeing p53 to trigger apoptosis specifically in senescent cells.

The D-retro-inverso modification—constructing the peptide from D-amino acids in reverse sequence—creates a molecule with identical binding surface topology but dramatically enhanced proteolytic stability. This senolytic approach—selectively eliminating senescent cells while sparing healthy ones—represents a targeted strategy for addressing cellular aging.

Mechanism of Action

FOXO4-DRI functions as a competitive inhibitor of the FOXO4-p53 protein-protein interaction that occurs specifically in senescent cells. In normal cells, p53 can freely trigger apoptosis in response to severe DNA damage. However, senescent cells express high levels of FOXO4, which enters the nucleus and physically binds p53, sequestering it away from apoptotic gene promoters. This FOXO4-p53 interaction prevents senescent cells from undergoing apoptosis despite their damaged state, allowing them to persist and secrete inflammatory factors (SASP—senescence-associated secretory phenotype).

FOXO4-DRI mimics the p53-binding interface of FOXO4, competitively displacing endogenous FOXO4 from p53. Freed p53 can then translocate to mitochondria and nuclear apoptotic gene promoters, triggering intrinsic apoptosis pathways through BAX/BAK activation and caspase cascade initiation. The D-retro-inverso design—constructing the peptide from D-amino acids in reverse sequence—creates a mirror-image structure with identical binding surface topology but dramatically enhanced proteolytic stability (half-life >24 hours vs minutes for L-peptides). Critically, the peptide shows selectivity: senescent cells with high FOXO4 expression and damaged DNA undergo apoptosis, while healthy cells with low FOXO4 and intact DNA are spared.

Key Research Findings

• Induces apoptosis in 65% of senescent fibroblasts while showing <5% toxicity to proliferating cells at 10 μM [Baar et al., 2017]
• Reduces p16INK4a+ senescent cell burden by 60% in naturally aged mice after 3 days treatment [Baar et al., 2017]
• Improves renal function by 42% and fur density by 38% in aged mice, reversing age-related phenotypes [Baar et al., 2017]
• Demonstrates FOXO4-p53 binding disruption with IC50 of 4.2 μM in fluorescence polarization assays [Baar et al., 2017]
• Shows tissue-independent senolytic effects: reduces senescent cells in kidney, liver, and fat by 50-75% [Kirkland & Tchkonia, 2017]

Research Applications

• Senescent cell biology
• FOXO4-p53 interaction studies
• Senolytic mechanism research
• Cellular aging models
• Apoptosis pathway research
• SASP modulation
• Targeted cellular aging interventions

Reconstitution & Use

Reconstitute with bacteriostatic water for laboratory use. For detailed reconstitution instructions and concentration ratios for your specific research application, see our reconstitution guide.

Storage & Handling

Store lyophilized at -20°C protected from moisture. Upon reconstitution, maintain at 2-8°C and use within 30 days. D-amino acid peptides demonstrate exceptional proteolytic stability.